Faron Pharmaceuticals Oy (DI) (FARN) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

Faron Pharmaceuticals Oy is a Finland-based, clinical-stage biopharmaceutical company focused on developing innovative cancer treatments that leverage the patient's own immune system, with a lead asset, bexmarilimab, currently in Phase I/II clinical trials. Faron Pharmaceuticals is listed under the ticker FARN.

FARN share price launched at 230p in 2015.

 

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings